Methyltransferase-Like 3-Mediated N6-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis

Dongqiong Xiao1, Deshuang Zhang1,2, Yi Qu1

  • 1Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Ministry of Education), NHC Key Laboratory of Chronobiology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Insights

Methyltransferase-like 3 (METTL3) impacts gene expression in bone diseases like osteoarthritis and osteoporosis. This review highlights METTL3 as a potential diagnostic biomarker and therapeutic target for these prevalent conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Osteoarthritis, osteoporosis, and osteosarcoma are significant bone pathologies with high mortality and therapeutic resistance.
  • Aberrant chondrocyte, osteoclast, and osteoblast function underlies these prevalent osseous conditions.
  • Investigating novel mechanistic insights is crucial for mitigating these health threats.

Purpose of the Study:

  • To systematically review and summarize current research on the role of Methyltransferase-like 3 (METTL3) in bone pathologies.
  • To evaluate the clinical significance and implications of METTL3 in osteoarthritis, osteoporosis, and osteosarcoma.
  • To elucidate METTL3's function in mediating N6-methyladenosine (m6A) modifications and its impact on cellular processes in bone diseases.

Main Methods:

  • Systematic review and aggregation of contemporary studies.
  • Analysis of existing literature on METTL3's involvement in osteoarthritis, osteoporosis, and osteosarcoma.
  • Examination of METTL3's role in RNA m6A modifications and gene expression regulation.

Main Results:

  • METTL3 plays a pivotal role in the pathogenesis of osteoarthritis, osteoporosis, and osteosarcoma.
  • METTL3 mediates m6A modifications on both messenger RNAs (mRNAs) and non-coding RNAs, influencing cellular functions.
  • Evidence suggests METTL3 acts as a risk gene in these bone conditions.

Conclusions:

  • METTL3 is significantly correlated with osteoarthritis, osteoporosis, and osteosarcoma.
  • METTL3 holds potential as a critical diagnostic biomarker for these bone pathologies.
  • Targeting METTL3 may offer a novel therapeutic strategy for managing bone diseases.

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
110
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.2K